摘要 |
<p>The present invention provides novel crystal forms of 2-[2-(4- chlorophenyl)ethoxy]adenosine of the formula processes for the production of such crystal forms, and methods for the manufacture of pharmaceutical compositions for the treatment of diseases or conditions modulated by the adenosine A2 receptors, in particular the A2A receptor, in a mammal in need thereof, by employing such crystal forms. The crystal forms of the present invention are especially useful in the preparation of topical compositions for accelerating wound healing, e.g., for the treatment of diabetic foot ulcers.</p> |
申请人 |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.;ANDRES, PATRICIA, M., J.;KELLY, RON C.;MOORMAN, ALLAN R.;STRANGE, MATTHEW |
发明人 |
ANDRES, PATRICIA, M., J.;KELLY, RON C.;MOORMAN, ALLAN R.;STRANGE, MATTHEW |